Page 146 - book
P. 146
Type Product Dosage form Strength Indication Status
A vial containing
300 mg of lyo-
immunosup- philized powder
pressants, for intravenous moderately to severely active ulcerative colitis
selective VedAryo infusion 108mg, moderately to severely active Crohn’s disease Available in
300mg
the market
immunosup- A pre-filled moderately to severely active chronic pouchitis
pressants syringe of 108 mg
for subcutaneous
injection
A vial containing IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
500 IU and 2000
Blood coagula- Coageight IU of lyophilized 500 IU inherited bleeding disorder caused by factor VIII Registered
tion factors 2000 IU deficiency
powder for intra-
venous infusion
145
